BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

653 related articles for article (PubMed ID: 25643269)

  • 1. Diagnosis and management of Clostridium difficile infection.
    Korman TM
    Semin Respir Crit Care Med; 2015 Feb; 36(1):31-43. PubMed ID: 25643269
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clostridium difficile infection in older adults: a review and update on its management.
    Kee VR
    Am J Geriatr Pharmacother; 2012 Feb; 10(1):14-24. PubMed ID: 22260856
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Best strategies in recurrent or persistent Clostridium difficile infection.
    Cocanour CS
    Surg Infect (Larchmt); 2011 Jun; 12(3):235-9. PubMed ID: 21767157
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnosis and management of Clostridium difficile infection.
    Dupont HL
    Clin Gastroenterol Hepatol; 2013 Oct; 11(10):1216-23; quiz e73. PubMed ID: 23542332
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fidaxomicin--the new drug for Clostridium difficile infection.
    Vaishnavi C
    Indian J Med Res; 2015 Apr; 141(4):398-407. PubMed ID: 26112840
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clostridium difficile and the disease it causes.
    Norén T
    Methods Mol Biol; 2010; 646():9-35. PubMed ID: 20597000
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New and emerging therapies in treatment of Clostridium difficile infection.
    Goyal H; Perisetti A; Rehman MR; Singla U
    Eur J Gastroenterol Hepatol; 2018 Jun; 30(6):589-597. PubMed ID: 29521664
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clostridium difficile infection: an update on epidemiology, risk factors, and therapeutic options.
    Lo Vecchio A; Zacur GM
    Curr Opin Gastroenterol; 2012 Jan; 28(1):1-9. PubMed ID: 22134217
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fidaxomicin (OPT-80) for the treatment of Clostridium difficile infection.
    Miller M
    Expert Opin Pharmacother; 2010 Jun; 11(9):1569-78. PubMed ID: 20446864
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Individualized treatment strategies for Clostridium difficile infections].
    Solbach P; Dersch P; Bachmann O
    Internist (Berl); 2017 Jul; 58(7):675-681. PubMed ID: 28589214
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current and emerging management options for Clostridium difficile infection: what is the role of fidaxomicin?
    Cornely OA
    Clin Microbiol Infect; 2012 Dec; 18 Suppl 6():28-35. PubMed ID: 23121552
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Challenges and opportunities in the management of Clostridium difficile infection.
    DuPont HL
    Expert Rev Gastroenterol Hepatol; 2014 Nov; 8(8):863-74. PubMed ID: 25012255
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epidemiology, diagnosis and treatment of Clostridium difficile infection.
    Bassetti M; Villa G; Pecori D; Arzese A; Wilcox M
    Expert Rev Anti Infect Ther; 2012 Dec; 10(12):1405-23. PubMed ID: 23253319
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The potential for emerging therapeutic options for Clostridium difficile infection.
    Mathur H; Rea MC; Cotter PD; Ross RP; Hill C
    Gut Microbes; 2014; 5(6):696-710. PubMed ID: 25564777
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fidaxomicin for the treatment of Clostridium difficile infections.
    Whitman CB; Czosnowski QA
    Ann Pharmacother; 2012 Feb; 46(2):219-28. PubMed ID: 22318930
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical review of Clostridium difficile infection: an update on treatment and prevention.
    Daniels LM; Kufel WD
    Expert Opin Pharmacother; 2018 Nov; 19(16):1759-1769. PubMed ID: 30220230
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of continued antibacterial therapy after diagnosis of hospital-onset Clostridium difficile infection: implications for antimicrobial stewardship.
    Harpe SE; Inocencio TJ; Pakyz AL; Oinonen MJ; Polk RE
    Pharmacotherapy; 2012 Aug; 32(8):744-54. PubMed ID: 23307522
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Update of treatment algorithms for Clostridium difficile infection.
    Ooijevaar RE; van Beurden YH; Terveer EM; Goorhuis A; Bauer MP; Keller JJ; Mulder CJJ; Kuijper EJ
    Clin Microbiol Infect; 2018 May; 24(5):452-462. PubMed ID: 29309934
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clostridium difficile infection: review.
    Czepiel J; Dróżdż M; Pituch H; Kuijper EJ; Perucki W; Mielimonka A; Goldman S; Wultańska D; Garlicki A; Biesiada G
    Eur J Clin Microbiol Infect Dis; 2019 Jul; 38(7):1211-1221. PubMed ID: 30945014
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clostridium difficile infection: current, forgotten and emerging treatment options.
    Drekonja DM
    J Comp Eff Res; 2014 Sep; 3(5):547-57. PubMed ID: 25350805
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.